Botulinum neurotoxin light chain protease (BoNT LC protease)

The Botulinum neurotoxin light chain protease is the catalytic domain of botulinum neurotoxins (BoNTs), zinc-dependent metalloproteases produced by Clostridium botulinum that specifically cleave SNARE proteins essential for neurotransmitter vesicle fusion at cholinergic synapses. This cleavage prevents acetylcholine release, resulting in flaccid paralysis, which underlies botulism poisoning but is harnessed therapeutically for conditions like muscle spasticity, dystonia, and cosmetic wrinkle reduction using serotypes A and B. Structurally, the ~50 kDa light chain (LC) features a zinc-binding HExxH motif and exosites that confer high substrate specificity, targeting SNAP-25 (BoNT/A, C), VAMP/synaptobrevin (BoNT/B, D, F), or syntaxin (BoNT/C). In disease, BoNTs cause severe neurotoxicity as the most potent known substances, while targeted inhibition of the protease is explored for countering bioterrorism or enhancing engineered toxins for cancer therapy, such as in differentiated neuroblastoma cells where SNAP-25/SNAP-23 loss induces apoptosis. Therapeutic BoNTs like onabotulinumtoxinA are delivered as holotoxins where the heavy chain facilitates neuronal uptake, but challenges include immunogenicity and dose-limiting paralysis risks. Research focuses on inhibitor design exploiting the protease's active site and exosites for antidotes.

Other names

Botulinum neurotoxin light chainBoNT light chainBoNT/A proteaseBoNT/B proteaseLC protease

Zinc-dependent proteolysis of SNAP-25 (BoNT/A, C); Cleavage of VAMP/synaptobrevin (BoNT/B, D, F); Cleavage of syntaxin (BoNT/C)